Cortisol metabolism after weight loss: Associations with 11 β-HSD type 1 and markers of obesity in women

Clinical Endocrinology

Volumn 78, Issue 5, 2013, Pages 700-705

  Rask, E ^a   Simonyte, K ^b   Lonn L ^c   Axelson, M ^d  

^a ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^b UMEÅ UNIVERSITY   (Sweden)

^c Rigshospitalet   (Denmark)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE 1; 5ALPHA TETRAHYDROCORTISOL; CORTISONE; CORTOL; CORTOLONE; GLUCOCORTICOID; HYDROCORTISONE; STEROID 5ALPHA REDUCTASE; TETRAHYDROCORTISOL; TETRAHYDROCORTISONE; UNCLASSIFIED DRUG;

ABDOMINAL SUBCUTANEOUS FAT; ADIPOSE TISSUE; ADULT; ARTICLE; BARIATRIC SURGERY; BODY COMPOSITION; CLINICAL ARTICLE; CORTICOSTEROID METABOLISM; DOWN REGULATION; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN TISSUE; INSULIN RESISTANCE; INTRAABDOMINAL FAT; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEROID EXCRETION; STOMACH BYPASS; WEIGHT REDUCTION;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1; ADULT; COHORT STUDIES; CORTISONE; FEMALE; HUMANS; HYDROCORTISONE; MIDDLE AGED; OBESITY; PROSPECTIVE STUDIES; TETRAHYDROCORTISOL; TETRAHYDROCORTISONE; WEIGHT LOSS;

EID: 84876143836     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2012.04333.x     Document Type: Article

References (29)

1. Andrew, R., Gale, C.R., Walker, B.R., et al,. (2002) Glucocorticoid metabolism and the Metabolic Syndrome: associations in an elderly cohort. Experimental and Clinical Endocrinology and Diabetes, 110, 284-290.
2. Michailidou, Z., Jensen, M.D., Dumesic, D.A., et al,. (2007) Omental 11beta-hydroxysteroid dehydrogenase 1 correlates with fat cell size independently of obesity. Obesity (Silver Spring), 15, 1155-1163.
3. Bujalska, I.J., Kumar, S., &, Stewart, P.M., (1997) Does central obesity reflect "Cushing's disease of the omentum"? Lancet, 349, 1210-1213.
4. Andrews, R.C., Herlihy, O., Livingstone, D.E., et al,. (2002) Abnormal cortisol metabolism and tissue sensitivity to cortisol in patients with glucose intolerance. Journal of Clinical Endocrinology and Metabolism, 87, 5587-5593.
5. Rask, E., Walker, B.R., Soderberg, S., et al,. (2002) Tissue-specific changes in peripheral cortisol metabolism in obese women: increased adipose 11beta-hydroxysteroid dehydrogenase type 1 activity. Journal of Clinical Endocrinology and Metabolism, 87, 3330-3336.
6. Sandeep, T.C., Andrew, R., Homer, N.Z., et al,. (2005) Increased in vivo regeneration of cortisol in adipose tissue in human obesity and effects of the 11beta-hydroxysteroid dehydrogenase type 1 inhibitor carbenoxolone. Diabetes, 54, 872-879.
7. Sigurjonsdottir, H.A., Andrew, R., Stimson, R.H., et al,. (2009) Lack of regulation of 11beta-hydroxysteroid dehydrogenase type 1 during short-term manipulation of GH in patients with hypopituitarism. European Journal of Endocrinology/European Federation of Endocrine Societies, 161, 375-380.
8. Fraser, R., Ingram, M.C., Anderson, N.H., et al,. (1999) Cortisol effects on body mass, blood pressure, and cholesterol in the general population. Hypertension, 33, 1364-1368.
9. Andrew, R., Smith, K., Jones, G.C., et al,. (2002) Distinguishing the activities of 11beta-hydroxysteroid dehydrogenases in vivo using isotopically labeled cortisol. Journal of Clinical Endocrinology and Metabolism, 87, 277-285.
10. Tomlinson, J.W., Finney, J., Gay, C., et al,. (2008) Impaired glucose tolerance and insulin resistance are associated with increased adipose 11beta-hydroxysteroid dehydrogenase type 1 expression and elevated hepatic 5alpha-reductase activity. Diabetes, 57, 2652-2660.
11. Palermo, M., Shackleton, C.H., Mantero, F., et al,. (1996) Urinary free cortisone and the assessment of 11 beta-hydroxysteroid dehydrogenase activity in man. Clinical Endocrinology, 45, 605-611.
12. Vogelzangs, N., Beekman, A.T., Milaneschi, Y., et al,. (2010) Urinary cortisol and six-year risk of all-cause and cardiovascular mortality. Journal of Clinical Endocrinology and Metabolism, 95, 4959-4964.
13. Lonn, L., Kvist, H., Ernest, I., et al,. (1994) Changes in body composition and adipose tissue distribution after treatment of women with Cushing's syndrome. Metabolism: Clinical and Experimental, 43, 1517-1522.
14. Bjorntorp, P., (2001) Do stress reactions cause abdominal obesity and comorbidities? Obesity reviews, 2, 73-86.
15. Vogelzangs, N., Beekman, A.T., Dik, M.G., et al,. (2009) Late-life depression, cortisol, and the metabolic syndrome. American Journal of Geriatric Psychiatry, 17, 716-721.
16. Tomlinson, J.W., Finney, J., Hughes, B.A., et al,. (2008) Reduced glucocorticoid production rate, decreased 5alpha-reductase activity, and adipose tissue insulin sensitization after weight loss. Diabetes, 57, 1536-1543.
17. Johnstone, A.M., Faber, P., Andrew, R., et al,. (2004) Influence of short-term dietary weight loss on cortisol secretion and metabolism in obese men. European Journal of Endocrinology/European Federation of Endocrine Societies, 150, 185-194.
18. Purnell, J.Q., Kahn, S.E., Samuels, M.H., et al,. (2009) Enhanced cortisol production rates, free cortisol, and 11beta-HSD-1 expression correlate with visceral fat and insulin resistance in men: effect of weight loss. American Journal of Physiology. Endocrinology and Metabolism, 296, E351-E357.
19. Stimson, R.H., Johnstone, A.M., Homer, N.Z., et al,. (2007) Dietary macronutrient content alters cortisol metabolism independently of body weight changes in obese men. Journal of Clinical Endocrinology and Metabolism, 92, 4480-4484.
20. Sjostrom, L., Lindroos, A.K., Peltonen, M., et al,. (2004) Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. New England Journal of Medicine, 351, 2683-2693.
21. Pontiroli, A.E., &, Morabito, A., (2011) Long-term prevention of mortality in morbid obesity through bariatric surgery. a systematic review and meta-analysis of trials performed with gastric banding and gastric bypass. Annals of Surgery, 253, 484-487.
22. Simonyte, K., Rask, E., Naslund, I., et al,. (2009) Obesity is accompanied by disturbances in peripheral glucocorticoid metabolism and changes in FA recycling. Obesity (Silver Spring), 17, 1982-1987.
23. Matthews, D.R., Hosker, J.P., Rudenski, A.S., et al,. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 28, 412-419.
24. Axelson, M., Sahlberg, B.L., &, Sjövall, J., (1981) Analysis of profiles of conjugated steroids in urine by ion-exchange separation and gas chromatography-mass spectrometry. Journal of Chromatography B: Biomedical Applications, 224, 355-370.
25. Sigurjonsdottir, H.A., Koranyi, J., Axelson, M., et al,. (2006) GH effect on enzyme activity of 11betaHSD in abdominal obesity is dependent on treatment duration. European Journal of Endocrinology/European Federation of Endocrine Societies, 154, 69-74.
26. Simonyte, K., Olsson, T., Naslund, I., et al,. (2010) Weight loss after gastric bypass surgery in women is followed by a metabolically favorable decrease in 11beta-hydroxysteroid dehydrogenase 1 expression in subcutaneous adipose tissue. Journal of Clinical Endocrinology and Metabolism, 95, 3527-3531.
27. Westerbacka, J., Yki-Jarvinen, H., Vehkavaara, S., et al,. (2003) Body fat distribution and cortisol metabolism in healthy men: enhanced 5beta-reductase and lower cortisol/cortisone metabolite ratios in men with fatty liver. Journal of Clinical Endocrinology and Metabolism, 88, 4924-4931.
28. Andrew, R., Phillips, D.I., &, Walker, B.R., (1998) Obesity and gender influence cortisol secretion and metabolism in man. Journal of Clinical Endocrinology and Metabolism, 83, 1806-1809.
29. Weaver, J.U., Taylor, N.F., Monson, J.P., et al,. (1998) Sexual dimorphism in 11 beta hydroxysteroid dehydrogenase activity and its relation to fat distribution and insulin sensitivity; a study in hypopituitary subjects. Clinical Endocrinology, 49, 13-20.